BLSM insider trading
NasdaqGS HealthcareBlossomHill Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
About BlossomHill Therapeutics, Inc.
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Company website: bhtherapeutics.com
BLSM insider activity at a glance
FilingIQ tracks 21 insider transactions for BLSM in filings since Aug 10, 2026. The most recent transaction is dated Aug 10, 2026.
Across the full history, 7 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BLSM insider trades is 64.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BLSM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BLSM?
- FilingIQ tracks 21 Form 4 insider transactions for BLSM (BlossomHill Therapeutics, Inc.), covering filings from Aug 10, 2026 onwards. 21 of those are dated within the last 90 days.
- Are BLSM insiders net buyers or net sellers?
- Across the full Form 4 history for BLSM, 7 transactions (33%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BLSM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BLSM in?
- BlossomHill Therapeutics, Inc. (BLSM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $532.19M.
Methodology & sources
Every BLSM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.